cas 34381-71-0|| where to buy [(2S)-1-methylpyrrolidin-2-yl]methanol

Product Name:[(2S)-1-methylpyrrolidin-2-yl]methanol

IUPAC Name:[(2S)-1-methylpyrrolidin-2-yl]methanol

Packing Unit	Available Stock	Price($)
CM328420-100g	in stock	ŮŌľ
CM328420-500g	in stock	ǪŤƿ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 34381-71-0 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:34381-71-0; Molecular Formula:C6H13NO; Melting Point:-; Smiles Code:OC[C@H]1N(C)CCC1; Density:

: Catalog Number:CM328420; Molecular Weight:115.18; Boiling Point:; MDL No:MFCD00011727; Storage:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Adagrasib; Jan. 10, 2024, EC approves KRAZATI (adagrasib) as a targeted treatment option for patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Adagrasib is an orally available, potent, irreversible, small molecule inhibitor of KRAS G12C mutant isoform for the treatment of solid tumours harbouring KRAS G12C oncogenic driver mutation. Adagrasib covalently binds to the mutant cysteine in KRAS G12C and locks the mutant KRAS protein in its inactive state, thereby preventing downstream signalling without affecting wild-type KRAS protein.